Bio Medica Laboratories saw its shares debut at a 20% discount on May 29, reflecting lower-than-expected investor interest. The company intends to use funds from its IPO for loan repayment and expanding manufacturing capabilities.
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.